IMCC
IM CannabisIMCC
IMCC
About: IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
Employees: 55
0
Funds holding %
of 7,296 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
9% more funds holding
Funds holding: 11 [Q4 2024] → 12 (+1) [Q1 2025]
0.04% less ownership
Funds ownership: 3.91% [Q4 2024] → 3.87% (-0.04%) [Q1 2025]
33% less capital invested
Capital invested by funds: $284K [Q4 2024] → $189K (-$95K) [Q1 2025]
Research analyst outlook
We haven’t received any recent analyst ratings for IMCC.
Financial journalist opinion
Based on 3 articles about IMCC published over the past 30 days
Neutral
Newsfile Corp
2 weeks ago
CSE Bulletin: Delist - IM Cannabis Corp. (IMCC)
Toronto, Ontario--(Newsfile Corp. - Le 28 mai/May 2025) - The common shares of IM Cannabis Corp. (the "Issuer") will be delisted from the CSE at market close, June 2, 2025. The Issuer will continue to trade on Nasdaq.
Neutral
PRNewsWire
2 weeks ago
IM Cannabis Announces Plans to Voluntarily Delist from the Canadian Securities Exchange
TORONTO and GLIL YAM, Israel , May 28, 2025 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announces that it has applied for a voluntary delisting of its common shares ("Shares") from the Canadian Securities Exchange (the "CSE"). The delisting from the CSE will not affect the Company's listing on NASDAQ and its Shares will continue trading on the NASDAQ under the symbol "IMCC".
Neutral
PRNewsWire
2 weeks ago
IM Cannabis Provides Corporate Updates
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO and GLIL YAM, Israel, May 27, 2025 /PRNewswire/ -- IM Cannabis Corp. ("IM Cannabis" or the "Company") (NASDAQ: IMCC) (CSE: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce the following corporate updates. Meeting Results Further to its press releases dated Aprill 11, 2025 (the " April 11 Release") and May 7, 2025 (the " May 7 Release"), the Company is pleased to announce results of its annual general and special meeting, held on Friday, May 23, 2025 (the "Meeting").
Neutral
Seeking Alpha
4 weeks ago
IM Cannabis Corp. (IMCC) Q1 2025 Earnings Call Transcript
IM Cannabis Corp. (NASDAQ:IMCC ) Q1 2025 Earnings Call May 15, 2025 9:00 AM ET Company Participants Anna Taranko - Director, Investor and Public Relations Oren Shuster - Chief Executive Officer Uri Birenberg - Chief Financial Officer Operator Good morning, and welcome to IM Cannabis' First Quarter 2025 Earnings Conference Call. Today's conference call is being recorded.
Neutral
PRNewsWire
1 month ago
IM Cannabis Reports First Quarter Financial Results
IMC Delivers Net Profit and 87% Gross Margin Improvement in Q1, Reflecting Strategic and Operational Progress TORONTO and GLIL YAM, Israel , May 15, 2025 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial results today for the first quarter ended March 31, 2025. All amounts are reported in Canadian dollars and compared to the quarter ended March 31, 2024, unless otherwise stated.
Neutral
PRNewsWire
1 month ago
IM Cannabis Announces Filing of Information Circular for Upcoming Annual General and Special Meeting and Provides Additional Information on the Focus Transaction
TORONTO and GLIL YAM, Israel , May 7, 2025 /PRNewswire/ -- IM Cannabis Corp. (Nasdaq: IMCC) (CSE: IMCC) (the "Company" or "IM Cannabis"), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that, further its news release dated April 11, 2025 (the " April 11 Release"), it has filed a management information circular (the "Circular") in connection with the upcoming annual general and special meeting of the shareholders of the Company ("Shareholders") to be held on May 23, 2025 (the "Meeting"). Capitalized terms not otherwise defined herein have the meanings attributed to them in the April 11 Release.
Neutral
PRNewsWire
1 month ago
IM Cannabis to Report First Quarter 2025 Financial Results on Thursday, May 15th at 9:00am ET
TORONTO and GLIL YAM, Israel , May 6, 2025 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the first quarter 2025 ended March 31, 2025, on Thursday, May 15, 2025, before the market opens. The Company will host a zoom web conference on the same day at 9:00am ET to discuss the results, followed by a question-and-answer session for the investment community.
Neutral
PRNewsWire
2 months ago
IM Cannabis Provides Corporate Updates
TORONTO and GLIL YAM, Israel , April 11, 2025 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IM Cannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, today announced the following corporate updates. Nasdaq Notification Letter The Company has received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") dated April 9, 2025, notifying the Company that it is no longer in compliance with Nasdaq Listing Rule 5550(b)(1).
Neutral
Seeking Alpha
2 months ago
IM Cannabis Corp. (IMCC) Q4 2024 Earnings Call Transcript
IM Cannabis Corp. (NASDAQ:IMCC ) Q4 2024 Earnings Conference Call March 31, 2025 9:00 AM ET Company Participants Anna Taranko - Director of Investor and Public Relations Oren Shuster - Chairman and Chief Executive Officer Uri Birenberg - Chief Financial Officer Conference Call Participants Aaron Grey - Alliance Global Partners Operator Good morning and welcome to IM Cannabis' Fourth Quarter and Full Year 2024 Earnings Conference Call. Today's conference call is being recorded.
Neutral
PRNewsWire
2 months ago
IM Cannabis Reports Fourth Quarter and Full Year 2024 Financial Results
Q4 2024 Caps a Year of Strategic and Operational Improvements for IMC with 25% Revenue Growth, 42% decrease in Operating Expenses, and $0.5M Adjusted EBITDA Profit TORONTO and GLIL YAM, Israel , March 31, 2025 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, is pleased to announce its financial results for the fourth quarter and year ended December 31, 2024. Unless otherwise stated, all amounts are reported in Canadian dollars and are compared to the quarter ended December 31, 2023.
Charts implemented using Lightweight Charts™